The Food and Drug Administration (FDA) has asked hospitals and pharmacies to recall batches of rosuvastatin — a drug to control cholesterol marketed as Crestor — which the agency said had been mixed with counterfeit drugs.
FDA official Chih Lan-hui (遲蘭慧) said that global biopharmaceutical company AstraZeneca received a report from a pharmacist in New Taipei City last month that its Crestor 10mg film-coated tablets might contain counterfeit drugs in similar packaging.
The company confirmed the product was fake after sending a sample abroad to be examined.
The FDA received the report from AstraZeneca on Thursday and the New Taipei District Prosecutors’ Office launched an investigation, Chih said.
Preliminary investigations showed that counterfeit drugs were mixed with batch number MV503 of Crestor, which was distributed in October last year.
National Health Insurance Administration (NHIA) data showed that more than 570,000 people are taking Crestor with about NT$2.3 billion (US$74.1 million) spent on the drug each year.
Chih said the counterfeit drug contained atorvastatin — another lipid-lowering medication — as its main ingredient, rather than rosuvastatin.
Taipei Department of Health official Wang Ming-li (王明理), director of the Food and Drug Division, yesterday said the department’s preliminary investigation at pharmacies in the city showed that another of the company’s film-coated cholesterol-lowering products might contain counterfeit drugs as well.
“We found 66 boxes of Crestor 10mg film-coated tablets with three different batch numbers and 44 boxes of 5mg film-coated tablets with one batch number” at a pharmacy that purchased the drugs from the same source as that which provided the confirmed fakes in New Taipei City, Wang said. “We collected them for testing.”
Taiwan Pharmacist Association spokesperson Shen Tsai-ying (沈采穎) said the patent on atorvastatin expired in November 2011, so the ingredients are 30 to 50 percent cheaper than rosuvastatin, so unscrupulous manufacturers of atorvastatin can captialize on the difference in cost.
Shen said many pharmacists reported that most of the MV503 batch has already been sold.
If people have medication from that batch, they should not take it, but should exchange it for the same drug from a different batch, Shen said.
Taiwan is to receive the first batch of Lockheed Martin F-16 Block 70 jets from the US late this month, a defense official said yesterday, after a year-long delay due to a logjam in US arms deliveries. Completing the NT$247.2 billion (US$7.69 billion) arms deal for 66 jets would make Taiwan the third nation in the world to receive factory-fresh advanced fighter jets of the same make and model, following Bahrain and Slovakia, the official said on condition of anonymity. F-16 Block 70/72 are newly manufactured F-16 jets built by Lockheed Martin to the standards of the F-16V upgrade package. Republic of China
Taiwan-Japan Travel Passes are available for use on public transit networks in the two countries, Taoyuan Metro Corp said yesterday, adding that discounts of up to 7 percent are available. Taoyuan Metro, the Taipei MRT and Japan’s Keisei Electric Railway teamed up to develop the pass. Taoyuan Metro operates the Taiwan Taoyuan International Airport MRT Line, while Keisei Electric Railway offers express services between Tokyo’s Narita Airport, and the Keisei Ueno and Nippori stations in the Japanese capital, as well as between Narita and Haneda airports. The basic package comprises one one-way ticket on the Taoyuan MRT Line and one Skyliner ticket on
A new tropical storm formed late yesterday near Guam and is to approach closest to Taiwan on Thursday, the Central Weather Administration (CWA) said. Tropical Storm Pulasan became the 14th named storm of the year at 9:25pm yesterday, the agency said. As of 8am today, it was near Guam traveling northwest at 21kph, it said. The storm’s structure is relatively loose and conditions for strengthening are limited, WeatherRisk analyst Wu Sheng-yu (吳聖宇) said on Facebook. Its path is likely to be similar to Typhoon Bebinca, which passed north of Taiwan over Japan’s Ryukyu Islands and made landfall in Shanghai this morning, he said. However, it
Starlux Airlines, Taiwan’s newest international carrier, has announced it would apply to join the Oneworld global airline alliance before the end of next year. In an investor conference on Monday, Starlux Airlines chief executive officer Glenn Chai (翟健華) said joining the alliance would help it access Taiwan. Chai said that if accepted, Starlux would work with other airlines in the alliance on flight schedules, passenger transits and frequent flyer programs. The Oneworld alliance has 13 members, including American Airlines, British Airways, Cathay Pacific and Qantas, and serves more than 900 destinations in 170 territories. Joining Oneworld would also help boost